血漿療法市場：按類型、應用、最終用戶和地區分類－市場規模、佔有率、前景和機會分析，2025-2032年

Plasma Therapy Market, By Type, By Application, By End-User, By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)-Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，血漿療法市場在2026年的價值為4.99億美元，預計到2033年將達到12.797億美元。預計從2026年到2033年，其複合年成長率將達到14.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	4.99億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	14.40%	2033年市場規模預測：	12.797億美元

血漿療法是一種很有前景的新冠病毒及許多其他罕見嚴重的治療方法。捐贈者的血液在處理中心進行處理以提取血漿。同樣，在治療新冠病毒感染患者時，也是從捐贈者身上分離血漿。捐贈者是已經康復的患者本人。捐贈者的血漿中含有抗原，即人體產生的對抗新冠病毒的抗體。捐贈者的血液在處理中心經過處理後，會被輸注到病人的血液中。

市場動態

監管機構對進行臨床試驗以開發新冠肺炎患者的新療法表現出濃厚的興趣。例如，2020年4月18日，印度藥品監管局（DCGI）批准了印度醫學研究理事會（ICMR）的提案。 ICMR是印度負責制定、協調和促進生物醫學研究的最高機構，該提案旨在進行一項針對新冠肺炎患者的康復者血漿臨床試驗。 ICMR提交了一份對該試驗感興趣的研究機構名單。康復者血漿療法是指從新冠肺炎康復患者的血液中提取抗體，然後將其輸注到目標患者的血液中。這項臨床試驗旨在評估康復者血漿在抑制新冠肺炎患者併發症的有效性，並評估使用含有SARS-CoV-2抗體的血漿治療新冠肺炎患者的安全性。預計臨床試驗數量的增加將拓寬新冠肺炎患者的治療選擇，並在預測期內推動全球血漿療法市場的成長。

各公司正在獲得監管部門批准，以建立新的生產設施。例如，2021年，武田藥品工業株式會社獲得美國食品藥物管理局（FDA）的批准，將在喬治亞科文頓附近新建一家製藥廠。該廠將生產「FLEXBUMIN 25% [人類血液白蛋白，USP，25%溶液]」。本產品適用於低血容、低白蛋白血症、燒傷、成人呼吸窘迫症候群（ARDS）、腎臟病症候群、心肺體外迴圈手術及新生兒溶血病。預計該新廠將擴大該公司的產品系列，並在預測期內促進全球血漿療法市場的成長。國際分銷商。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球血漿療法市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
全球血漿療法市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球血漿療法市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Octapharma AG
Top Bio Group Co., Ltd
Bio Products Laboratory Ltd
Kedrion SpA
Grifols, SA
CSL
Biotest AG
Takeda Pharmaceutical Company Limited
DePuy Synthes（A subsidiary of Johnson & Johnson Services, Inc.）
Regen Lab SA
LFB SA
ImmunoTek Plasma

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI4155

Plasma Therapy Market is estimated to be valued at USD 499.0 Mn in 2026 and is expected to reach USD 1,279.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 499.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	14.40%	2033 Value Projection:	USD 1,279.7 Mn

Plasma therapy is a promising treatment against coronaviruses, and many rare other and serious disorders. The blood that is donated by the donor is processed in a processing facility to obtain plasma. Similarly, for the treatment of coronavirus-infected patients, the plasma is isolated from the donor. The donor is also the patient who has recovered from the infection. The donor plasma consists of antibodies that were generated in order to fight the antigens, i.e., the coronavirus. The blood from the donor is processed in processing centers and then injected into the blood of the patients.

Market Dynamics

Regulatory authorities are interested in conducting clinical trials for the development of new treatment options for coronavirus infected patients. For instance, on April 18, 2020, The Drug Controller General of India (DCGI) accepted the proposal of the Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination, and promotion of biomedical research, for conducting clinical trials of convalescent plasma in COVID-19 patients. The ICMR has submitted a list of institutes that are interested in the trial. In convalescent plasma therapy, the antibodies are recovered from the blood of patients who have recovered from COVID-19 and injected into the blood of injected patients. The clinical trial aims to assess the efficacy of convalescent plasma to limit complications in COVID-19 patients and to evaluate the safety of treatment with anti SARS-CoV-2 plasma in coronavirus-infected patients. The rising number of clinical trials is expected to increase treatment options for coronavirus infected patients and spur global plasma therapy market growth during the forecast period.

Companies are receiving approvals from regulatory authorities for the setup of a new manufacturing facility. For instance, in 2021, Takeda Pharmaceutical Company Limited received approval from the U.S Food and Drug Administration (U.S FDA) for its new pharmaceutical manufacturing facility near Covington, Georgia. The facility will produce FLEXBUMIN 25% [Albumin (Human), USP, 25% Solution]. The medicine is indicated for hypovolemia, hypoalbuminemia, burns, Adult Respiratory Distress Syndrome, and nephrosis, cardiopulmonary bypass surgery, and hemolytic disease of newborns. The new facility will expand the product portfolio of the company which is expected to favor the global plasma therapy market growth during the forecast period.international distributors.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global plasma therapy market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Octapharma AG, Top Bio Group Co., Ltd, Bio Products Laboratory Ltd, Kedrion S.p.A, Grifols, S.A, CSL, Biotest AG, Takeda Pharmaceutical Company Limited, DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.), Regen Lab SA, LFB S.A, ImmunoTek Plasma.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global plasma therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasma therapy market.

Detailed Segmentation:

Global Plasma Therapy Market, By Type (Revenue, USD Mn, 2021 - 2033)
Pure PRP
Leucocyte-rich PRP
Pure Platelet-rich Fibrin (PRF)
Leukocyte-rich Fibrin (L-PRF)
Global Plasma Therapy Market, By Appication (Revenue, USD Mn, 2021 - 2033)
Infectious Diseases
Dental
Nerve Injury
Cardiac Muscle Injury
Other Applications
Global Plasma Therapy Market, By End user (Revenue, USD Mn, 2021 - 2033)
Hospitals and Clinics
Research Institutes
Others
Global Plasma Therapy Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Octapharma AG
Top Bio Group Co., Ltd
Bio Products Laboratory Ltd
Kedrion S.p.A
Grifols, S.A
Cochin Shipyard Limited
Biotest AG
Takeda Pharmaceutical Company Limited
DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.)
Regen Lab SA
LFB S.A
ImmunoTek Plasma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End user
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Mergers and Acquisition
Product Approvals
Partnerships and Collaborations
Research and Development Activities
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Plasma Therapy Market, By Type, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pure PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Leucocyte-rich PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Pure Platelet-rich Fibrin (PRF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Leukocyte-rich Fibrin (L-PRF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Plasma Therapy Market, By Application, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Nerve Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Cardiac Muscle Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)

6. Global Plasma Therapy Market, By End user, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)

7. Global Plasma Therapy Market, By Region, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Octapharma AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Top Bio Group Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio Products Laboratory Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Kedrion S.p.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Grifols, S.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CSL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biotest AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regen Lab SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LFB S.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ImmunoTek Plasma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies